| Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers GB Frisoni, M Boccardi, F Barkhof, K Blennow, S Cappa, K Chiotis, ... The Lancet Neurology 16 (8), 661-676, 2017 | 609 | 2017 |
| FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort SP Caminiti, T Ballarini, A Sala, C Cerami, L Presotto, R Santangelo, ... NeuroImage: Clinical 18, 167-177, 2018 | 133 | 2018 |
| Early identification of MCI converting to AD: a FDG PET study M Pagani, F Nobili, S Morbelli, D Arnaldi, A Giuliani, J Öberg, N Girtler, ... European journal of nuclear medicine and molecular imaging 44, 2042-2052, 2017 | 108 | 2017 |
| Volume of interest-based [18F] fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC … M Pagani, F De Carli, S Morbelli, J Öberg, A Chincarini, GB Frisoni, ... NeuroImage: Clinical 7, 34-42, 2015 | 103 | 2015 |
| Longitudinal reproducibility of default-mode network connectivity in healthy elderly participants: a multicentric resting-state fMRI study J Jovicich, L Minati, M Marizzoni, R Marchitelli, R Sala-Llonch, ... Neuroimage 124, 442-454, 2016 | 101 | 2016 |
| Multisite Longitudinal Reliability of Tract-Based Spatial Statistics in Diffusion Tensor Imaging of Healthy Elderly Subjects J Jovicich, M Marizzoni, B Bosch, D Bartrés-Faz, J Arnold, J Benninghoff, ... NeuroImage, 2014 | 96 | 2014 |
| Visual versus semi-quantitative analysis of 18F-FDG-PET in amnestic MCI: an European Alzheimer's Disease Consortium (EADC) project S Morbelli, A Brugnolo, I Bossert, A Buschiazzo, GB Frisoni, S Galluzzi, ... Journal of Alzheimer's Disease 44 (3), 815-826, 2015 | 87 | 2015 |
| Free water elimination improves test–retest reproducibility of diffusion tensor imaging indices in the brain: A longitudinal multisite study of healthy elderly subjects A Albi, O Pasternak, L Minati, M Marizzoni, D Bartrés‐Faz, N Bargallo, ... Human brain mapping 38 (1), 12-26, 2017 | 84 | 2017 |
| Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework V Garibotto, K Herholz, M Boccardi, A Picco, A Varrone, A Nordberg, ... Neurobiology of aging 52, 183-195, 2017 | 83 | 2017 |
| Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder? D Arnaldi, F De Carli, A Picco, M Ferrara, J Accardo, I Bossert, F Famà, ... Neurobiology of aging 36 (12), 3300-3305, 2015 | 75 | 2015 |
| Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson’s disease and probable RBD D Arnaldi, S Morbelli, A Brugnolo, N Girtler, A Picco, M Ferrara, J Accardo, ... Parkinsonism & related disorders 29, 47-53, 2016 | 72 | 2016 |
| Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework K Chiotis, L Saint-Aubert, M Boccardi, A Gietl, A Picco, A Varrone, ... Neurobiology of aging 52, 214-227, 2017 | 61 | 2017 |
| What predicts cognitive decline in de novo Parkinson's disease? D Arnaldi, C Campus, M Ferrara, F Famà, A Picco, F De Carli, J Accardo, ... Neurobiology of aging 33 (6), 1127. e11-1127. e20, 2012 | 55 | 2012 |
| Prediction of cognitive worsening in de novo Parkinson's disease: clinical use of biomarkers D Arnaldi, F De Carli, F Famà, A Brugnolo, N Girtler, A Picco, M Pardini, ... Movement Disorders 32 (12), 1738-1747, 2017 | 49 | 2017 |
| The role of the serotonergic system in REM sleep behavior disorder D Arnaldi, F Famà, F De Carli, S Morbelli, M Ferrara, A Picco, J Accardo, ... Sleep 38 (9), 1505-1509, 2015 | 46 | 2015 |
| Metabolic correlates of Rey auditory verbal learning test in elderly subjects with memory complaints A Brugnolo, S Morbelli, D Arnaldi, F De Carli, J Accardo, I Bossert, ... Journal of Alzheimer's Disease 39 (1), 103-113, 2014 | 44 | 2014 |
| Brain functional network in Alzheimer's disease: diagnostic markers for diagnosis and monitoring G Rodriguez, D Arnaldi, A Picco International Journal of Alzheimer’s Disease 2011, 2011 | 41 | 2011 |
| Predicting the transition from normal aging to Alzheimer's disease: a statistical mechanistic evaluation of FDG-PET data M Pagani, A Giuliani, J Öberg, A Chincarini, S Morbelli, A Brugnolo, ... Neuroimage 141, 282-290, 2016 | 40 | 2016 |
| Test‐retest reliability of the default mode network in a multi‐centric f MRI study of healthy elderly: Effects of data‐driven physiological noise correction techniques R Marchitelli, L Minati, M Marizzoni, B Bosch, D Bartrés‐Faz, BW Müller, ... Human brain mapping 37 (6), 2114-2132, 2016 | 40 | 2016 |
| 18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage S Morbelli, M Bauckneht, D Arnaldi, A Picco, M Pardini, A Brugnolo, ... European journal of nuclear medicine and molecular imaging 44, 2073-2083, 2017 | 39 | 2017 |
